Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Treatment response and outcome of children with T-cell acute lymphoblastic leukemia expressing the gamma-delta T-cell receptor.

Pui CH, Pei D, Cheng C, Tomchuck SL, Evans SN, Inaba H, Jeha S, Raimondi SC, Choi JK, Thomas PG, Dallas MH.

Oncoimmunology. 2019 May 17;8(8):1599637. doi: 10.1080/2162402X.2019.1599637. eCollection 2019.

PMID:
31413907
2.

Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses.

Zamora AE, Crawford JC, Allen EK, Guo XJ, Bakke J, Carter RA, Abdelsamed HA, Moustaki A, Li Y, Chang TC, Awad W, Dallas MH, Mullighan CG, Downing JR, Geiger TL, Chen T, Green DR, Youngblood BA, Zhang J, Thomas PG.

Sci Transl Med. 2019 Jun 26;11(498). pii: eaat8549. doi: 10.1126/scitranslmed.aat8549.

PMID:
31243155
3.

Rapid cloning, expression, and functional characterization of paired αβ and γδ T-cell receptor chains from single-cell analysis.

Guo XZ, Dash P, Calverley M, Tomchuck S, Dallas MH, Thomas PG.

Mol Ther Methods Clin Dev. 2016 Jan 27;3:15054. doi: 10.1038/mtm.2015.54. eCollection 2016.

4.

Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.

Thomas P, Santiago T, Dallas MH.

Bone Marrow Transplant. 2016 May;51(5):735-7. doi: 10.1038/bmt.2015.309. Epub 2016 Jan 11. No abstract available.

PMID:
26752145
5.

Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.

Tomchuck SL, Leung WH, Dallas MH.

Biol Blood Marrow Transplant. 2015 Jan;21(1):39-49. doi: 10.1016/j.bbmt.2014.10.014. Epub 2014 Oct 18.

6.

Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.

Perko R, Kang G, Sunkara A, Leung W, Thomas PG, Dallas MH.

Biol Blood Marrow Transplant. 2015 Jan;21(1):130-6. doi: 10.1016/j.bbmt.2014.09.027. Epub 2014 Oct 16.

7.

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

Srinivasan A, Panetta JC, Cross SJ, Pillai A, Triplett BM, Shook DR, Dallas MH, Hartford C, Sunkara A, Kang G, Jacobsen J, Choi J, Leung W.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1224-8. doi: 10.1016/j.bbmt.2014.04.020. Epub 2014 Apr 23.

8.

Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, Ware R, Leung W.

Biol Blood Marrow Transplant. 2013 May;19(5):820-30. doi: 10.1016/j.bbmt.2013.02.010. Epub 2013 Feb 14.

9.

Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors.

Shook DR, Triplett BM, Srinivasan A, Hartford C, Dallas MH, Pillai A, Laver J, Leung W.

Biol Blood Marrow Transplant. 2013 Feb;19(2):291-7. doi: 10.1016/j.bbmt.2012.10.001. Epub 2012 Oct 9.

10.

Notch target Hes5 ensures appropriate Notch induced T- versus B-cell choices in the thymus.

Varnum-Finney B, Dallas MH, Kato K, Bernstein ID.

Blood. 2008 Mar 1;111(5):2615-20. Epub 2007 Nov 29.

11.

Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.

Dallas MH, Varnum-Finney B, Martin PJ, Bernstein ID.

Blood. 2007 Apr 15;109(8):3579-87. Epub 2007 Jan 9.

12.

Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells.

Dallas MH, Varnum-Finney B, Delaney C, Kato K, Bernstein ID.

J Exp Med. 2005 May 2;201(9):1361-6. Epub 2005 Apr 25.

Supplemental Content

Loading ...
Support Center